These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
347 related articles for article (PubMed ID: 30396385)
1. Analgesic effects of the novel α₂δ ligand mirogabalin in a rat model of spinal cord injury. Domon Y; Kitano Y; Makino M Pharmazie; 2018 Nov; 73(11):659-661. PubMed ID: 30396385 [TBL] [Abstract][Full Text] [Related]
2. Anxiolytic effects of the novel α Murasawa H; Kobayashi H; Saeki K; Kitano Y Psychopharmacology (Berl); 2020 Jan; 237(1):189-197. PubMed ID: 31515584 [TBL] [Abstract][Full Text] [Related]
3. Analgesic effects of mirogabalin, a novel ligand for α Saeki K; Yasuda SI; Kato M; Kano M; Domon Y; Arakawa N; Kitano Y Naunyn Schmiedebergs Arch Pharmacol; 2019 Jun; 392(6):723-728. PubMed ID: 30770951 [TBL] [Abstract][Full Text] [Related]
4. Effects of mirogabalin, a novel ligand for the α₂δ subunit of voltage-gated calcium channels, on N-type calcium channel currents of rat dorsal root ganglion culture neurons. Kitano Y; Wakimoto S; Tamura S; Kubota K; Domon Y; Arakawa N; Saito M; Sava B; Buisson B Pharmazie; 2019 Mar; 74(3):147-149. PubMed ID: 30961679 [TBL] [Abstract][Full Text] [Related]
5. Anxiolytic-like effects of mirogabalin, a novel ligand for α Murasawa H; Kobayashi H; Yasuda SI; Saeki K; Domon Y; Arakawa N; Kubota K; Kitano Y Pharmacol Rep; 2020 Jun; 72(3):571-579. PubMed ID: 32270470 [TBL] [Abstract][Full Text] [Related]
6. Binding Characteristics and Analgesic Effects of Mirogabalin, a Novel Ligand for the Domon Y; Arakawa N; Inoue T; Matsuda F; Takahashi M; Yamamura N; Kai K; Kitano Y J Pharmacol Exp Ther; 2018 Jun; 365(3):573-582. PubMed ID: 29563324 [TBL] [Abstract][Full Text] [Related]
7. Calcium channel alpha-2-delta-1 protein upregulation in dorsal spinal cord mediates spinal cord injury-induced neuropathic pain states. Boroujerdi A; Zeng J; Sharp K; Kim D; Steward O; Luo DZ Pain; 2011 Mar; 152(3):649-655. PubMed ID: 21239111 [TBL] [Abstract][Full Text] [Related]
8. Mirogabalin activates the descending noradrenergic system by binding to the α Oyama M; Watanabe S; Iwai T; Tanabe M J Pharmacol Sci; 2021 May; 146(1):33-39. PubMed ID: 33858653 [TBL] [Abstract][Full Text] [Related]
9. [Pharmacological, pharmacodynamics, and clinical profile of mirogabalin besylate (Tarlige Kitano Y; Kai K; Yamamura N; Yoshiba S; Kuroha M Nihon Yakurigaku Zasshi; 2019; 154(6):352-361. PubMed ID: 31787689 [TBL] [Abstract][Full Text] [Related]
11. Contribution of the spinal cord BDNF to the development of neuropathic pain by activation of the NR2B-containing NMDA receptors in rats with spinal nerve ligation. Geng SJ; Liao FF; Dang WH; Ding X; Liu XD; Cai J; Han JS; Wan Y; Xing GG Exp Neurol; 2010 Apr; 222(2):256-66. PubMed ID: 20079352 [TBL] [Abstract][Full Text] [Related]
12. Administration of ONO-2506 suppresses neuropathic pain after spinal cord injury by inhibition of astrocytic activation. Ishiguro H; Kaito T; Hashimoto K; Kushioka J; Okada R; Tsukazaki H; Kodama J; Bal Z; Ukon Y; Takenaka S; Makino T; Sakai Y; Yoshikawa H Spine J; 2019 Aug; 19(8):1434-1442. PubMed ID: 30974239 [TBL] [Abstract][Full Text] [Related]
13. Upregulation of calcium channel alpha-2-delta-1 subunit in dorsal horn contributes to spinal cord injury-induced tactile allodynia. Kusuyama K; Tachibana T; Yamanaka H; Okubo M; Yoshiya S; Noguchi K Spine J; 2018 Jun; 18(6):1062-1069. PubMed ID: 29355786 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of the spinal astrocytic JNK/MCP-1 pathway activation correlates with the analgesic effects of tanshinone IIA sulfonate in neuropathic pain. Tang J; Zhu C; Li ZH; Liu XY; Sun SK; Zhang T; Luo ZJ; Zhang H; Li WY J Neuroinflammation; 2015 Mar; 12():57. PubMed ID: 25889689 [TBL] [Abstract][Full Text] [Related]
15. Spinal 5-HT3 receptor mediates nociceptive effect on central neuropathic pain; possible therapeutic role for tropisetron. Nasirinezhad F; Hosseini M; Karami Z; Yousefifard M; Janzadeh A J Spinal Cord Med; 2016; 39(2):212-9. PubMed ID: 26338446 [TBL] [Abstract][Full Text] [Related]
17. Pannexin 1: a novel participant in neuropathic pain signaling in the rat spinal cord. Bravo D; Ibarra P; Retamal J; Pelissier T; Laurido C; Hernandez A; Constandil L Pain; 2014 Oct; 155(10):2108-15. PubMed ID: 25102401 [TBL] [Abstract][Full Text] [Related]
18. Antihyperalgesic, Antiallodynic, and Antinociceptive Effects of Cebranopadol, a Novel Potent Nociceptin/Orphanin FQ and Opioid Receptor Agonist, after Peripheral and Central Administration in Rodent Models of Neuropathic Pain. Tzschentke TM; Linz K; Frosch S; Christoph T Pain Pract; 2017 Nov; 17(8):1032-1041. PubMed ID: 28112482 [TBL] [Abstract][Full Text] [Related]
19. The Novel Gabapentinoid Mirogabalin Prevents Upregulation of α2δ-1 Subunit of Voltage-Gated Calcium Channels in Spinal Dorsal Horn in a Rat Model of Spinal Nerve Ligation. Domon Y; Kobayashi N; Kubota K; Kitano Y; Ueki H; Shimojo Y; Ishikawa K; Ofune Y Drug Res (Stuttg); 2023 Jan; 73(1):54-60. PubMed ID: 36216339 [TBL] [Abstract][Full Text] [Related]
20. The novel analgesic compound OT-7100 (5-n-butyl-7-(3,4,5-trimethoxybenzoylamino)pyrazolo[1,5-a]pyrimid ine) attenuates mechanical nociceptive responses in animal models of acute and peripheral neuropathic hyperalgesia. Yasuda T; Iwamoto T; Ohara M; Sato S; Kohri H; Noguchi K; Senba E Jpn J Pharmacol; 1999 Jan; 79(1):65-73. PubMed ID: 10082319 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]